question
stringlengths 47
751
| answer
stringlengths 4
183
| slide_id
stringlengths 23
23
⌀ | project
stringclasses 1
value | f1024
stringlengths 139
139
⌀ | f2048
stringlengths 138
138
⌀ | f4096
stringlengths 139
139
⌀ |
|---|---|---|---|---|---|---|
what was the tumour type determined to be? A. fibroadenoma B. lipoma C. malignant invasive ductal carcinoma D. benign cystadenoma | C. malignant invasive ductal carcinoma | TCGA-PL-A8LZ-01A-01-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_1024.npy |
what was the age of the patient? A. 5 years old B. 10 years old C. 15 years old D. 20 years old | A. 5 years old | TCGA-PL-A8LZ-01A-01-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_1024.npy |
what was the stroma composed of? A. blood vessels only B. tumour cells only C. lymphocytes and tumour cells D. all of the above | C. lymphocytes and tumour cells | TCGA-PL-A8LZ-01A-01-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_1024.npy |
what was the cytoplasmic staining? A. glycolipid B. phospholipid C. sphingolipid D. amphophilic | D. amphophilic | TCGA-PL-A8LZ-01A-01-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868_1_1024.npy |
what procedure was performed on the patient? A. appendectomy B. mastectomy C. tonsillectomy D. rhinoplasty | B. mastectomy | TCGA-S3-AA17-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_1024.npy |
what type of carcinoma did the patient have in the breast? A. invasive lobular carcinoma B. invasive ductal carcinoma C. basal cell carcinoma D. squamous cell carcinoma | B. invasive ductal carcinoma | TCGA-S3-AA17-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_1024.npy |
was the breast also affected by carcinoma? A. yes B. no C. not mentioned D. both breasts were affected | A. yes | TCGA-S3-AA17-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49_1_1024.npy |
what is the final diagnosis of the patient? A. basal cell carcinoma B. infiltrating ductal carcinoma C. infiltrating lobular carcinoma D. squamous cell carcinoma | C. infiltrating lobular carcinoma | TCGA-A2-A0EX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_1024.npy |
was there any evidence of venous/lymphatic invasion? A. yes B. no C. cannot be determined D. not mentioned | B. no | TCGA-A2-A0EX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_1024.npy |
what is the her2 status of the tumor? A. positive B. negative C. cannot be determined D. not mentioned | B. negative | TCGA-A2-A0EX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_1024.npy |
what was found in the additional deep margin? A. malignant breast tissue B. benign breast tissue C. abscess D. cyst | B. benign breast tissue | TCGA-A2-A0EX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_1024.npy |
were there any pre-operative or post-operative diagnoses provided? A. yes B. no C. cannot be determined D. not mentioned | B. no | TCGA-A2-A0EX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EX-01Z-00-DX1.F4C293E9-9BB2-48A1-8080-5F3082E219C5_1_1024.npy |
is there lymphovascular invasion identified in the tumor? A. yes B. no C. not provided D. not mentioned | A. yes | TCGA-BH-A0B7-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_1_1024.npy |
what is the hormone receptor status of the tumor? A. er/pr negative, her2/neu negative B. er/pr positive, her2/neu negative C. er/pr negative, her2/neu positive D. er/pr positive, her2/neu positive | D. er/pr positive, her2/neu positive | TCGA-BH-A0B7-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC_1_1024.npy |
what were the hormone receptors found in the neoplastic cell nuclei? A. estrogen receptors B. progesterone receptors C. both estrogen and progesterone receptors D. neither estrogen nor progesterone receptors | C. both estrogen and progesterone receptors | TCGA-D8-A1Y3-01Z-00-DX2 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_1024.npy |
did the patient have her2 gene amplification? A. yes B. no C. insufficient information D. positive but not amplified | B. no | TCGA-D8-A1Y3-01Z-00-DX2 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_1024.npy |
what was the main type of carcinoma found in the breast? A. ductal carcinoma in situ B. lobular carcinoma C. invasive ductal carcinoma D. metastatic carcinoma | C. invasive ductal carcinoma | TCGA-D8-A1Y3-01Z-00-DX2 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_1024.npy |
where were the metastases found? A. liver B. lungs C. brain D. axillary lymph nodes | D. axillary lymph nodes | TCGA-D8-A1Y3-01Z-00-DX2 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_1024.npy |
what evidence of invasion was found? A. epidermal invasion B. lymphatic invasion C. neural invasion D. vascular invasion | D. vascular invasion | TCGA-D8-A1Y3-01Z-00-DX2 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA_1_1024.npy |
what type of cancer was found in the breast? A. invasive ductal carcinoma B. invasive lobular carcinoma C. fibroadenoma D. benign breast cyst' | A. invasive ductal carcinoma | TCGA-D8-A1J8-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_1024.npy |
which receptors were found in the neoplastic cell nuclei? A. estrogen and progesterone receptors B. her2 protein receptors C. androgen receptors D. histamine receptors' | A. estrogen and progesterone receptors | TCGA-D8-A1J8-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_1024.npy |
what were the findings in the glandular tissue? A. hyperplasia B. fibrocystic changes C. adenoma D. ductal carcinoma in situ' | B. fibrocystic changes | TCGA-D8-A1J8-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D_1_1024.npy |
what type of tumor was found during the mastectomy? A. ductal carcinoma in situ B. invasive tumor C. lobular carcinoma in situ D. metastatic tumor | B. invasive tumor | TCGA-BH-A0BD-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_1024.npy |
what type of necrosis is present in the tumor? A. microcalcification necrosis B. apoptotic necrosis C. liquefactive necrosis D. comedo necrosis | D. comedo necrosis | TCGA-BH-A0BD-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_1024.npy |
were the resection margins positive or negative for carcinoma? A. positive B. negative C. inconclusive D. not mentioned | B. negative | TCGA-BH-A0BD-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_1024.npy |
which receptors tested positive in the tumor? A. her-2/neu B. estrogen receptor C. progesterone receptor D. none of the above | B. estrogen receptor | TCGA-BH-A0BD-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_1024.npy |
what additional changes were observed in the biopsy specimen? A. hormonal imbalance changes B. benign changes C. inflammatory changes D. none of the above | B. benign changes | TCGA-BH-A0BD-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD_1_1024.npy |
what type of cancer did the patient have in the breast? A. ductal carcinoma B. lobular carcinoma C. mucinous carcinoma D. medullary carcinoma | A. ductal carcinoma | TCGA-BH-A18I-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_1024.npy |
what additional condition was found along with the invasive ductal carcinoma? A. invasive lobular carcinoma B. ductal carcinoma in situ (dcis) C. metastatic carcinoma D. medullary carcinoma | B. ductal carcinoma in situ (dcis) | TCGA-BH-A18I-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_1024.npy |
which receptors are positive in the invasive tumor cells? A. estrogen receptor and progesterone receptor B. human epidermal growth factor receptor 2 (her-2) C. androgen receptor and estrogen receptor D. progesterone receptor and her-2 | A. estrogen receptor and progesterone receptor | TCGA-BH-A18I-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18_1_1024.npy |
what is the diagnosis based on the pathological slide? A. fibrocystic changes B. benign breast tissue C. stage ii breast cancer D. positive perineural invasion. | C. stage ii breast cancer | TCGA-AO-A03R-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_1024.npy |
what is the stage of the tumor? A. stage i breast cancer B. stage ii breast cancer C. stage iii breast cancer D. stage iv breast cancer | B. stage ii breast cancer | TCGA-AO-A03R-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_1024.npy |
what are the findings in the breast tissue? A. biopsy site changes and fibrocystic changes B. extensive vascular invasion and positive perineural invasion C. involvement of invasive or in situ carcinoma D. calcifications in the benign breast tissue | A. biopsy site changes and fibrocystic changes | TCGA-AO-A03R-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8_1_1024.npy |
what was the primary reason for the patient's breast removal? A. multifocal ductal carcinoma B. fibrocystic changes C. high-grade adenocarcinoma D. metastatic adenocarcinoma | A. multifocal ductal carcinoma | TCGA-AR-A0TW-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_1024.npy |
how many additional tumors were found in the breast? A. 1 B. 2 C. 3 D. 4 | C. 3 | TCGA-AR-A0TW-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_1024.npy |
what type of changes were observed in the patient's breast? A. nonproliferative fibrocystic changes B. ductal adenocarcinoma C. mastectomy-related changes D. metastatic adenocarcinoma | A. nonproliferative fibrocystic changes | TCGA-AR-A0TW-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_1024.npy |
did the excised nipples from both breasts show any signs of malignancy? A. no B. yes C. not mentioned D. malignancy was inconclusive | A. no | TCGA-AR-A0TW-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174_1_1024.npy |
what was the histologic grade of the carcinoma? A. well differentiated B. moderately differentiated C. poorly differentiated D. undifferentiated | B. moderately differentiated | TCGA-E9-A226-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_1_1024.npy |
what was the overall diagnosis? A. infiltrating papillary carcinoma B. mucinous carcinoma C. infiltrating ductal carcinoma D. tubular carcinoma | C. infiltrating ductal carcinoma | TCGA-E9-A226-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a_1_1024.npy |
what is the her2 status of the invasive tumor cells? A. positive B. negative C. equivocal D. not tested | C. equivocal | TCGA-BH-A42T-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_1024.npy |
what is the result of the her2/neu amplification test? A. positive B. negative C. equivocal D. not tested | C. equivocal | TCGA-BH-A42T-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_1024.npy |
what type of changes are present in the non-neoplastic breast tissue? A. fibroadenoma B. ductal carcinoma in situ C. fibrocystic changes with apocrine metaplasia and ductal epithelial hyperplasia D. no changes | C. fibrocystic changes with apocrine metaplasia and ductal epithelial hyperplasia | TCGA-BH-A42T-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_1024.npy |
what is the next recommended step for her2 status testing? A. repeat her2/neu immunohistochemistry B. proceed with treatment based on equivocal result C. do not perform further testing D. perform her2/neu amplification test again | A. repeat her2/neu immunohistochemistry | TCGA-BH-A42T-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A42T-01Z-00-DX1.6E4609B9-BE7E-4CA9-A1C0-A77A7DEFBB2B_1_1024.npy |
what type of breast cancer has the patient been diagnosed with? A. invasive ductal carcinoma in the left breast B. invasive lobular carcinoma in the left breast C. ductal carcinoma in situ in the right breast D. lobular carcinoma in situ in the right breast | B. invasive lobular carcinoma in the left breast | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what does the pathological slide confirm regarding the sentinel nodes? A. absence of cancer cells B. presence of cancer cells C. inconclusive results D. no information provided | B. presence of cancer cells | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what further testing will be performed to determine the status of? A. hormone receptors B. her2 protein expression C. tumor size D. lymphovascular invasion | B. her2 protein expression | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what was found in the surgical margins? A. cancer cells B. benign breast tissue C. lymphovascular invasion D. no information provided | B. benign breast tissue | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what does the slide mention regarding the status of surgical margins? A. clear margins B. positive margins C. inconclusive results D. no information provided | B. positive margins | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what information does the slide provide regarding the tumor characteristics? A. tumor grade, size, and lymphovascular invasion B. hormone receptor status C. presence of cancer cells in sentinel nodes D. presence of her2 protein expression | A. tumor grade, size, and lymphovascular invasion | TCGA-AO-A1KS-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A1KS-01Z-00-DX1.349F9BCA-C9F0-43B4-BA6A-D20039E1C720_1_1024.npy |
what is the histologic type of the invasive adenocarcinoma in the breast tissue? A. medullary B. lobular C. papillary D. ductal | D. ductal | TCGA-B6-A1KI-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_1024.npy |
what is the nuclear grade of the in situ carcinoma? A. 1 B. 2 C. 3 D. not applicable | A. 1 | TCGA-B6-A1KI-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_1024.npy |
what is the nottingham combined histologic grade of the invasive adenocarcinoma? A. 1 out of 3 B. 2 out of 3 C. 3 out of 3 D. not applicable | B. 2 out of 3 | TCGA-B6-A1KI-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_1024.npy |
what is the margin status of the biopsy? A. positive B. negative C. close D. not applicable | C. close | TCGA-B6-A1KI-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_1024.npy |
what is the immunohistochemical stain for cytokeratin? A. positive B. negative C. pending D. not applicable | B. negative | TCGA-B6-A1KI-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA_1_1024.npy |
what is the nottingham histologic grade of the invasive ductal carcinoma? A. grade 1 (3+3+2) B. grade 2 (3+3+2) C. grade 3 (3+3+2) D. grade 4 (3+3+2) | C. grade 3 (3+3+2) | TCGA-D8-A1JM-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_1024.npy |
how many mitoses are observed per 10 high-power fields? A. 26 B. 10 C. 3 D. 2 | A. 26 | TCGA-D8-A1JM-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_1024.npy |
what was found around the tumor in the microscopic examination? A. fibrosis B. granulomas C. lymphocytic reaction D. no abnormalities | C. lymphocytic reaction | TCGA-D8-A1JM-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_1024.npy |
what protein staining is negative in the immunohistochemical examination? A. estrogen receptor staining B. progesterone receptor staining C. her2 protein staining D. all of the above | C. her2 protein staining | TCGA-D8-A1JM-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E_1_1024.npy |
what was the nottingham grade of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4 | C. grade 3 | TCGA-BH-A0B4-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_1024.npy |
what was the total nottingham score of the tumor? A. 3/9 B. 6/9 C. 9/9 D. 12/9 | C. 9/9 | TCGA-BH-A0B4-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_1024.npy |
what was the status of her2 receptors? A. positive B. negative C. not specified D. inconclusive | C. not specified | TCGA-BH-A0B4-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B4-01Z-00-DX1.A2CB0BF4-32F9-48FD-9B96-A744013BADDB_1_1024.npy |
what is the diagnosis based on the findings? A. invasive lobular carcinoma B. invasive ductal carcinoma C. metastatic carcinoma D. lobular carcinoma in situ | D. lobular carcinoma in situ | TCGA-E2-A3DX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_1024.npy |
what is the nottingham grade of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4 | D. grade 4 | TCGA-E2-A3DX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_1024.npy |
which immunohistochemistry stain was positive at the inked margin? A. cytokeratin ae1/3 B. acid-fast bacteria stain C. gomori methenamine silver stain D. none of the above | D. none of the above | TCGA-E2-A3DX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_1024.npy |
what is the etiology of the granulomas? A. invasive lobular carcinoma B. invasive ductal carcinoma C. metastatic carcinoma D. uncertain | D. uncertain | TCGA-E2-A3DX-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A3DX-01Z-00-DX1.75094CA2-CE51-4886-A564-BD10043A6E4C_1_1024.npy |
what is the grade of the medullary carcinoma? A. well-differentiated B. moderately differentiated C. poorly differentiated D. undifferentiated | B. moderately differentiated | TCGA-E9-A3QA-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_1024.npy |
was there any extracapsular invasion? A. yes B. no C. not specified D. cannot be determined | C. not specified | TCGA-E9-A3QA-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_1024.npy |
what is the nottingham histologic score based on? A. tumor size, involvement of lymph nodes, extracapsular invasion B. tubule formation, nuclear pleomorphism, mitotic count C. tumor grade, presence of neo-adjuvant treatment, pathologic findings D. extent of the tumor, tumor differentiation, lymph node involvement | B. tubule formation, nuclear pleomorphism, mitotic count | TCGA-E9-A3QA-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_1024.npy |
was neo-adjuvant treatment administered to the patient? A. yes B. no C. not specified D. cannot be determined | C. not specified | TCGA-E9-A3QA-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A3QA-01Z-00-DX1.9D664AF3-9ABD-4EED-B826-4C4FBFC33F3E_1_1024.npy |
what were the histological patterns observed? A. diffuse, streaming, mosaic, storiform B. positive C. negative D. not specified | A. diffuse, streaming, mosaic, storiform | TCGA-C8-A12P-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_1024.npy |
what was the grade of nuclear atypia? A. not specified B. grade 1 C. grade 2 D. present | B. grade 1 | TCGA-C8-A12P-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_1024.npy |
what was the cellular differentiation for lymphomatous cells? A. positive B. not specified C. negative D. present | C. negative | TCGA-C8-A12P-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_1024.npy |
what was the histological diagnosis? A. carcinoma B. squamous C. negative D. not specified | A. carcinoma | TCGA-C8-A12P-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D_1_1024.npy |
what is the grade of the carcinoma? A. combined nuclear grade 2, tubule formation 1, mitotic activity 3 B. combined nuclear grade 1, tubule formation 2, mitotic activity 4 C. combined nuclear grade 3, tubule formation 3, mitotic activity 3 D. combined nuclear grade 2, tubule formation 3, mitotic activity 4 | D. combined nuclear grade 2, tubule formation 3, mitotic activity 4 | TCGA-BH-A0HB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_1024.npy |
is there angiolymphatic invasion present? A. yes B. no C. uncertain D. not mentioned | D. not mentioned | TCGA-BH-A0HB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_1024.npy |
is there any dermal lymphatic invasion present? A. yes B. no C. uncertain D. not mentioned | D. not mentioned | TCGA-BH-A0HB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_1024.npy |
is there any involvement of the surgical margins by the in situ component? A. yes B. no C. uncertain D. not mentioned | D. not mentioned | TCGA-BH-A0HB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_1024.npy |
what is the her2/neu status? A. positive B. negative C. uncertain D. not mentioned | D. not mentioned | TCGA-BH-A0HB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB_1_1024.npy |
what is the grade of the invasive carcinoma? A. high B. low C. moderate D. not mentioned | C. moderate | TCGA-EW-A1J3-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_1024.npy |
what is the her2 status of the tumor? A. positive B. negative C. not mentioned D. in situ | A. positive | TCGA-EW-A1J3-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_1024.npy |
what type of carcinoma is present in the slide? A. ductal carcinoma B. lobular carcinoma C. squamous carcinoma D. not mentioned | B. lobular carcinoma | TCGA-EW-A1J3-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_1024.npy |
what further testing is recommended in the slide? A. radiation therapy B. chemotherapy C. hormonal therapy D. immunohistochemistry and gene amplification analysis | D. immunohistochemistry and gene amplification analysis | TCGA-EW-A1J3-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J3-01Z-00-DX1.F736F6F4-0859-439A-A417-98B520C8D65A_1_1024.npy |
what type of breast cancer was identified? A. ductal carcinoma B. invasive lobular carcinoma C. medullary carcinoma D. infiltrating carcinoma | B. invasive lobular carcinoma | TCGA-D8-A3Z5-01Z-00-DX3 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_1024.npy |
what was the histologic grade of the tumor? A. high histologic grade (nhg3) B. intermediate histologic grade (nhg2) C. low histologic grade (nhg1) D. not mentioned in the slide | C. low histologic grade (nhg1) | TCGA-D8-A3Z5-01Z-00-DX3 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_1024.npy |
what was the status of hormone receptors in the cancer cells? A. estrogen receptor-negative and progesterone receptor-negative B. estrogen receptor-negative and progesterone receptor-positive C. estrogen receptor-positive and progesterone receptor-negative D. estrogen receptor-positive and progesterone receptor-positive | D. estrogen receptor-positive and progesterone receptor-positive | TCGA-D8-A3Z5-01Z-00-DX3 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_1024.npy |
what was the status of the her2 protein in the invasive cancer cells? A. detected B. not detected C. partially detected D. cannot be determined from the slide | B. not detected | TCGA-D8-A3Z5-01Z-00-DX3 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A3Z5-01Z-00-DX3.BB83C7D4-F795-47E7-9A5C-7DBF0EB7FDAA_1_1024.npy |
what is the histologic type of the invasive carcinoma? A. invasive ductal carcinoma B. lobular carcinoma in situ C. benign breast tissue D. reactive sinus histiocytosis | A. invasive ductal carcinoma | TCGA-S3-AA11-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_1024.npy |
what is the hormone receptor status of the tumor? A. er and pr negative B. er and pr positive C. er positive and pr negative D. er negative and pr positive | B. er and pr positive | TCGA-S3-AA11-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_1024.npy |
what is the grade of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4 | B. grade 2 | TCGA-S3-AA11-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_1024.npy |
are there any margins involved by invasive carcinoma or dcis? A. yes B. no C. insufficient data to determine D. there is no mention of margins | B. no | TCGA-S3-AA11-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_1024.npy |
what is the her2/neu status? A. her2/neu amplified B. her2/neu non-amplified C. insufficient data to determine D. there is no mention of her2/neu | B. her2/neu non-amplified | TCGA-S3-AA11-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD_1_1024.npy |
what was the diagnosis of the patient who underwent breast modified radical mastectomy? A. invasive ductal carcinoma, B. lobular carcinoma in situ, C. invasive lobular carcinoma, D. ductal carcinoma in situ. | C. invasive lobular carcinoma, | TCGA-OL-A66N-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_1024.npy |
what is the histologic grade of the tumor? A. iii, B. iv, C. ii, D. i. | C. ii, | TCGA-OL-A66N-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_1024.npy |
what is the expression of progesterone receptor (pr)? A. moderate, B. weak, C. strong, D. no expression. | D. no expression. | TCGA-OL-A66N-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_1024.npy |
what is the ptnm staging of the tumor? A. pt3, n0, mx, B. pt2, n2, m1, C. pt4, n3, mx, D. pt3, n3, mx. | D. pt3, n3, mx. | TCGA-OL-A66N-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_1024.npy |
is the her2 antigen amplified in the tumor? A. yes, B. no, C. positive, D. negative. | B. no, | TCGA-OL-A66N-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A66N-01Z-00-DX1.ABDA3014-7B3A-4D48-A415-CB9608491ECB_1_1024.npy |
what is the tumor grade of the invasive lobular carcinoma found in the breast tissue? A. grade 2 B. grade 1 C. grade 3 D. non-tumorous breast tissue | A. grade 2 | TCGA-A7-A4SB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_1_1024.npy |
what type of tissue was observed in the non-tumorous breast tissue? A. dense fibrosis B. ductal carcinoma in situ C. calcification D. invasive lobular carcinoma | A. dense fibrosis | TCGA-A7-A4SB-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SB-01Z-00-DX1.E8925605-5189-441E-A719-92CFC1118B0B_1_1024.npy |
what is the grade of the invasive carcinoma? A. intermediate grade B. high grade C. low grade D. moderate grade | A. intermediate grade | TCGA-AR-A1AY-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_1_1024.npy |
what type of carcinoma is found outside the main tumor mass? A. invasive carcinoma B. ductal carcinoma in situ C. metastatic carcinoma D. squamous cell carcinoma | B. ductal carcinoma in situ | TCGA-AR-A1AY-01Z-00-DX1 | TCGA-BRCA | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_0_1024.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_1_512.npy | /bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81_1_1024.npy |